Psychiatric
Pre-Columbian era, Andean civilizations (historical accounts of behavioral disturbances associated with coca use, documented through later ethnographic and archaeological records)
Stimulant psychosis, a severe psychiatric disturbance associated with the use of stimulant substances, was first systematically described in the mid-twentieth century as amphetamines became widely used in medical and military contexts. Earlier centuries had produced scattered accounts of mania and derangement linked to stimulating preparations, though these were rarely understood as belonging to a coherent clinical category. The condition's history is inseparable from the broader social and medical history of stimulant substances across cultures.
Historical Narrative
Long before synthetic stimulants existed, healers and observers in various cultures recorded states of extreme agitation, paranoia, and mental disturbance in individuals who had consumed stimulating plant preparations. Coca leaf use in Andean civilizations stretching back thousands of years was occasionally associated with reports of disordered and erratic behavior in those who consumed large quantities, though indigenous frameworks interpreted such episodes through spiritual and cultural lenses rather than as a discrete medical syndrome. Similarly, the use of khat in East African and Arabian Peninsula societies generated periodic accounts of severe behavioral disturbances, which traditional healers attributed to spiritual interference or individual moral weakness.
The widespread introduction of cocaine in Western medicine during the 1880s generated some of the earliest clinical observations that would later be recognized as stimulant-induced psychosis. Sigmund Freud's enthusiastic 1884 essay Über Coca promoted cocaine as a therapeutic agent for numerous conditions, and the subsequent flood of cocaine products into European and American markets was followed by a growing body of case literature describing extreme paranoia, hallucinations, and violent behavior in habitual users. Carl Koller, who pioneered cocaine's use in ophthalmological procedures, and other contemporary physicians began documenting these disturbing mental states, though interpretations varied widely. Some physicians attributed the symptoms to underlying mental weakness in the affected individual rather than to the substance itself.
The German physician Erlenmeyer published critical assessments of cocaine in the late 1880s, arguing that the drug could produce a distinct form of derangement in users, and he was among the first Western clinicians to frame habitual cocaine use as capable of generating psychosis in previously healthy individuals. His work contributed to a growing skepticism about cocaine's safety that would eventually lead to its restriction in many countries by the early twentieth century.
The amphetamine era, beginning with the commercial introduction of Benzedrine in the 1930s, produced a new wave of stimulant-related psychiatric observations. Amphetamines were distributed widely to soldiers during the Second World War, and military and civilian physicians began accumulating case reports of psychotic breaks in individuals using the substances. P.H. Connell's landmark 1958 monograph Amphetamine Psychosis, based on a systematic study of cases in British hospitals, established the condition as a recognizable clinical entity for the first time. Connell documented that a paranoid psychosis indistinguishable in presentation from schizophrenia could appear in amphetamine users and typically resolved after the substance was withdrawn, a finding that had profound implications for psychiatric theory.
Connell's work sparked considerable scientific interest because it suggested that a purely chemical disruption could produce what appeared to be a functional psychosis, lending support to emerging biological theories of psychiatric illness. Researchers in subsequent decades used stimulant psychosis as a pharmacological model to investigate the role of dopamine in psychotic states, as the knowledge that amphetamines powerfully affected dopamine systems in the brain offered a potential neurochemical framework for understanding psychosis more broadly. This line of inquiry shaped psychiatric research throughout the latter half of the twentieth century.
Key Historical Figures
Historical narrative only — this page describes how Stimulant psychosis was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.